Ken Sayre

Ken Sayre has a strong background in finance and operations, with experience in various senior leadership roles. Ken is currently working as the Vice President of Finance and U.S. Operations at Oxford BioTherapeutics. Prior to this, Ken was the Principal Consultant at Sayre Consulting from 2019 to 2021. Ken also served as the Senior Director of Financial Planning and Analysis at Dynavax Technologies from 2011 to 2019, where they managed a team and oversaw strategic financial planning for clinical trials and initiatives. Ken's earlier experience includes roles as a Principal at KAS Consulting, Senior Director of Finance at Fluidigm Corporation, Senior Director of Finance at XDx, Inc., and Director of Finance at Applied Biosystems. Overall, Ken brings extensive experience in financial management, business planning, and decision support to their current role.

Ken Sayre has a Master of Business Administration - MBA degree from Santa Clara University, with a focus on Finance, General. Ken also holds a Bachelor of Business Administration - BBA degree from the Santa Clara University Leavey School of Business.